Presented by Johan Vansteenkiste

Respiratory Oncology Unit, Dept. Pulmonology, Univ.
Hospital KU Leuven, Leuven Lung Cancer Group.

Click here to access the case study

1

  • Learning Objectives

    On completing this assessment, you should to be able to:

    • Describe the unique challenges in treating patients with squamous NSCLC
    • Explain the current treatment strategies for patients with squamous NSCLC,
      according to ESMO guidelines
    • Compare and contrast first-line treatment strategies for patients with squamous NSCLC
    • Discuss new and emerging relapse treatment pathways for patients with squamous NSCLC

     

     

    Please allow approximately 20 – 30 minutes to complete this module.
    Your progress will be tracked allowing you to return to your most recently viewed screen.

  • Johan Vansteenkiste

    Respiratory Oncology Unit, Dept. Pulmonology, Univ.
    Hospital KU Leuven, Leuven Lung Cancer Group.

    Vansteenkiste Pic

    Professor Vansteenkiste is Professor of Internal Medicine in the Faculty of Medicine at the Catholic University of Leuven, Belgium, and Head of Clinic in the Respiratory Oncology Unit and its Clinical Trial Unit at the Leuven University Hospital. He studied medicine at the University of Leuven before becoming a Board Certified Pulmonologist-Oncologist.

    He had additional training in respiratory oncology at the European School of Oncology in Milan, Italy, and in respiratory endoscopy at the Laser Centre in Marseille, France, before gaining his PhD at the University of Leuven in 1996.

    Professor Vansteenkiste is an active member of different international societies such as ESMO, IASLC, ASCO, and others. He was Secretary of the Thoracic Oncology Assembly of the ERS and a member of the ERS School Board in 2009-2012.
    He was a member of the Board of Directors of IASLC in 2009-2013. He is a member of the ESMO Lung Educational Group and Guidelines Group, and chaired the European Lung Cancer Conference in April 2015.

    He is the principal investigator or co-investigator in several clinical trials in the area of lung cancer.  He is Associate Editor at the Annals of Oncology, a member of the editorial board of several other journals, and author or co-author of more than 250 peer-reviewed papers and book chapters.

  • Target Audience

    This case study is intended for medical and radiation oncologists, thoracic surgeons, pulmonologists, respiratory physicians and any other clinicians involved in the diagnosis, treatment and follow-up of patients with non–small cell lung cancer (NSCLC).

    The purpose of this interactive case study of is for participants to test their knowledge and clinical practices in the management of patients with NSCLC, and gain knowledge of emerging first-line and relapse treatment pathways.